Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.44 |
| ▸ | ADH1B | P00325 | 1/20 | 0.43 |
| ▸ | ADH1C | P00326 | 1/20 | 0.43 |
| ▸ | ADH1A | P07327 | 1/20 | 0.43 |
| ▸ | ADH4 | P08319 | 1/20 | 0.43 |
| ▸ | ADH7 | P40394 | 1/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.37 |
| ▸ | FDPS | P14324 | 3/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11900455 | 1.00 | TSHR (0.44) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL5613606 | 1.00 | TSHR (0.44) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL1157220 | 1.00 | TSHR (0.44) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL5613440 | 1.00 | TSHR (0.44) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL11901187 | 1.00 | TSHR (0.44) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL10555437 | 1.00 | TSHR (0.44) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL5613583 | 1.00 | TSHR (0.44) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL5613218 | 1.00 | TSHR (0.44) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL5613613 | 1.00 | TSHR (0.44) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL5613158 | 1.00 | TSHR (0.44) | TSHROPRM1ADH1BADH1CADH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025198839-A1 | HYBRID COMPOSITIONS FROM A TYPE OF LIGHTLY BRANCHED OLEFINS | ExxonMobil Technology and Engineering Company (US) | 2025-09-25 | — | — | WO | disclosed |
| CN-118201905-A | Cationic lipid | 武田药品工业株式会社 | 2024-06-14 | — | — | CN | disclosed |
| CN-114716599-B | Olefin copolymer and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-02-13 | — | — | CN | disclosed |
| WO-2023085299-A1 | CATIONIC LIPID | 武田薬品工業株式会社 | 2023-05-19 | — | — | WO | disclosed |
| CN-114716599-A | Olefin copolymer and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-07-08 | — | — | CN | disclosed |
| EP-2984055-B1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | MATERIA INC (US) | 2018-10-17 | — | — | EP | disclosed |
| US-10000775-B2 | Biosynthesis of 1-undecene and related terminal olefins | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-06-19 | — | — | US | disclosed |
| EP-2678410-B1 | COMPOSIITONS COMPRISING MIXTURES OF C10-C13 ALKYLPHENYL SULFONATES | PROCTER & GAMBLE (US) | 2017-09-13 | — | — | EP | disclosed |
| US-9758445-B2 | Preparation of surfactants via cross-metathesis | MATERIA, INC. (US) | 2017-09-12 | — | — | US | disclosed |
| US-9663459-B2 | Preparation of surfactants via cross-metathesis | MATERIA, INC. (US) | 2017-05-30 | — | — | US | disclosed |
| US-20070270521-A1 | Transition metal compound, polymerization-initiator system comprising the same, and process for producing polymer | SUMITOMO CHEMICAL COMPANY, LIMITED | 2007-11-22 | — | — | US | disclosed |
| WO-2007113180-A1 | PROCESS FOR PREPARING AN AQUEOUS POLYMER DISPERSION | BASF SE (DE) | 2007-10-11 | — | — | WO | disclosed |
| WO-2007082904-A1 | N-BA/ALKENE COPOLYMERS AS A GRAFT BASE FOR ABS POLYMERS | BASF SE (DE) | 2007-07-26 | — | — | WO | disclosed |
| WO-2007082839-A2 | POLYMER POWDER WITH HIGH RUBBER CONTENT AND PRODUCTION THEREOF | BASF SE (DE) | 2007-07-26 | — | — | WO | disclosed |
| US-20070078075-A1 | Method for producing alkylaryl compounds and alklaryl sulphonates | BASF AKTIENGESELLSCHAFT (DE) | 2007-04-05 | — | — | US | disclosed |
| WO-2007012616-A1 | PROCESS FOR PREPARING AN AQUEOUS ADDITION-POLYMER DISPERSION | BASF SE (DE) | 2007-02-01 | — | — | WO | disclosed |
| EP-1682467-A1 | METHOD FOR PRODUCING ALKYLARYL COMPOUNDS AND ALKYLARYL SULPHONATES | BASF AKTIENGESELLSCHAFT (DE) | 2006-07-26 | — | — | EP | disclosed |
| WO-2005042448-A1 | METHOD FOR PRODUCING ALKYLARYL COMPOUNDS AND ALKYLARYL SULPHONATES | BASF AKTIENGESELLSCHAFT (DE) | 2005-05-12 | — | — | WO | disclosed |
| US-5059629-A | Polymeric foam substrate containing particles or fibers of a blend of biocidal copolymer ionically bonded to a water insoluble thermoplastic resin | THE DOW CHEMICAL COMPANY (US) | 1991-10-22 | — | — | US | disclosed |
| US-5004760-A | Biocidal foams | THE DOW CHEMICAL COMPANY (US) | 1991-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070270521-A1 | Transition metal compound, polymerization-initiator system comprising the same, and process for producing polymer | CARM1, CPN1, CCNT1 | TSHR 4291/4885OPRM1 290/4885ADH1B 1621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.